In this study, we set out to determine the role of the BRD9 bromodomain, selecting a panel of five AML cell lines representing various morphologic classes (Table 1) to interpret results based on a range of phenotypes and driver mutations.. The gene discussed is BRD9; the disease is acute myeloid leukemia.